Asklepios Hospital Barmbek, Hamburg – Germany
About Dr. med. Axel Stang
Prof. Dr. med. Axel Stang is an internationally respected German Medical Oncologist and Haematologist based in Hamburg, widely recognised as a leading Medical Oncologist specialist in Hamburg, Germany for hematology, medical oncology, palliative medicine, and interdisciplinary cancer care.
- 39+ years of clinical and academic experience in internal medicine, hematology, and oncology
- Senior Advisor Oncology at Asklepios Klinik Barmbek (former Chief Physician 2010–2024, Medical Director 2016–2022)
- ESMO Certification in Medical Oncology; board-certified in Internal Medicine & Hematology/Oncology
- Asklepios Innovation in der Medizin Award — 1st Prize, 2012 (for SIRT in inoperable liver malignancies)
- 68+ publications with 3,461+ citations and a ResearchGate professorial profile
Qualifications & Credentials
Medical Degrees
- Vordiplom in Biology / Molecular Genetics — Technical University of Karlsruhe, Germany
- Medical Graduation (Staatsexamen / Approbation) — University of Hamburg, Germany
- Doctorate (Dr. med.) — University of Hamburg (under Prof. Dietel)
- Habilitation and Full University Professorship — Semmelweis University, Budapest, Hungary
Fellowships & Special Training
- ESMO Certification in Medical Oncology
- Board-Certified Specialist — Internal Medicine, Germany
- Board-Certified Specialist — Hematology and Medical Oncology, Germany
- Qualification for disease-specific genetic counselling — German Genetic Diagnostics Act
- Fachverantwortlicher Dozent (Faculty Lead) at Asklepios Campus Hamburg — Genetics & Genomics and Oncology
Certifications & Accreditations
- German Medical Association (Bundesärztekammer) Registration
- Hamburg Medical Chamber (Ärztekammer Hamburg) — Registered Specialist
- European Society for Medical Oncology (ESMO) Certification
- Full Professor — Semmelweis University, Budapest
Areas of Expertise
Major Conditions Treated
- Acute and Chronic Leukemias
- Hodgkin & Non-Hodgkin Lymphoma
- Multiple Myeloma
- Myelodysplastic Syndrome (MDS)
- Solid Tumors (Lung, GI, Breast, Genitourinary)
- Liver Metastases from Colorectal & Other Primaries
- Hepatocellular Carcinoma (HCC)
- Cholangiocarcinoma
- Inoperable Liver Malignancies
- Anemia and Bleeding Disorders
- Cancer-Related Pain & Palliative Care Needs
- Advanced-Stage Cancers requiring Palliative Medicine
Sub-specialties
- Hematology & Medical Oncology: Comprehensive chemotherapy, targeted therapy, and immunotherapy for hematologic malignancies and solid tumors — a trusted medical oncologist specialist in Hamburg, Germany.
- Interventional & Loco-Regional Cancer Therapy: Pioneer of Selective Internal Radiation Therapy (SIRT) for inoperable liver malignancies at Asklepios Hamburg (Award winner, 2012).
- Palliative Medicine: Multidisciplinary palliative care programmes for advanced cancer patients.
- Genetic Oncology: Disease-specific genetic counselling under the German Genetic Diagnostics Act.
- DKG-Certified Onkologisches Zentrum Leadership: Founder/developer of the DKG-certified Oncology Center Barmbek (2016) — for international patients seeking best cancer treatment in Germany.
Advanced Procedures & Treatments
- Selective Internal Radiation Therapy (SIRT) for Liver Malignancies
- Radiofrequency Ablation (RFA) for Liver Tumors
- Chemosaturation for Uveal Melanoma Liver Metastases
- Systemic Chemotherapy & Targeted Therapy
- Immunotherapy (Checkpoint Inhibitors, Monoclonal Antibodies)
- Autologous & Allogeneic Stem Cell Transplantation Referral
- Bone Marrow Biopsy & Molecular Diagnostics
- Contrast-Enhanced Abdominal Ultrasound (Onkologische Sonographie)
- Palliative Medicine & Pain Management
- Genetic Counselling for Hereditary Cancer
List of Disease and Treatment for which Dr. med. Axel Stang can be consulted
Professional Experience
Current Affiliation
- Asklepios Klinik Barmbek, Rübenkamp 220, 22307 Hamburg, Germany — Senior Advisor Oncology, Department of Oncology and Palliative Medicine, Since January 2025
- Asklepios Campus Hamburg (Asklepios Medical School, Lohmühlenstr. 5, Haus P, 20099 Hamburg) — Fachverantwortlicher Dozent (Faculty Lead) in Genetics & Genomics and Oncology
- Semmelweis University, Budapest — Full University Professor
Past Affiliations
- Asklepios Klinik Barmbek — Chief Physician (Chefarzt), Department of Oncology and Palliative Medicine, 2010–2024
- Asklepios Klinik Barmbek — Medical Director (Ärztlicher Direktor), 2016–2022
- Asklepios Klinik Altona — Senior Consultant in Hematology, Oncology, and Stem Cell Transplantation (Past)
- MVZ Onkologie — Founder/Director (Past)
- Head of Oncology Center Barmbek and Barmbek Oncology Outpatient Center (Past)
Academic & Research Roles
- Full Professor — Semmelweis University, Budapest
- Fachverantwortlicher Dozent (Faculty Lead) — Asklepios Campus Hamburg (Genetics & Genomics, Oncology)
- Chairman — Council of Scientific Student Circles (Wissenschaftliche Studentenkreise), Asklepios Campus Hamburg
- Author — 68+ peer-reviewed publications with 3,461+ citations (ResearchGate)
- Faculty — Ongoing teaching responsibilities in bedside teaching, ultrasound courses, and oncology nursing education
Key Achievements
- 39+ years of experience in medical oncology, hematology, and palliative medicine
- Department leadership since 2010 with average annual growth of 200+ new patients
- Founder of MVZ Onkologie
- Established DKG-certified Oncology Center Barmbek (2016) as part of Asklepios Tumor Center Hamburg
- Successfully secured Barmbek Oncology Center's place in the Hamburg Bed Plan (2017)
- Asklepios Innovation in der Medizin Award — 1st Prize, 2012
- 68+ publications and 3,461+ citations on ResearchGate
Awards & Recognitions
National & International Awards
- Asklepios Award "Innovation in der Medizin" — 1st Prize, 2012 (for introduction of Selective Internal Radiation Therapy for inoperable liver malignancies at Asklepios Klinik Altona/Barmbek)
Professional Memberships
- German Cancer Community (Deutsche Krebsgesellschaft)
- European Society for Medical Oncology (ESMO)
- German Society for Ultrasound in Medicine (DEGUM)
- Sonography Working Committee of Hamburg
- German Medical Association (Bundesärztekammer)
- Hamburg Medical Chamber (Ärztekammer Hamburg)
Research & Publications
Published Papers (Selected)
- Stang A et al. Review paper on radiofrequency ablation (RFA) as treatment of colorectal cancer liver metastases — PubMed-indexed.
- Stang A et al. Studies on ultrasonography (US)-guided RFA for liver tumors — Hamburg clinical series.
- Research on chemosaturation in liver metastases of uveal melanoma — 5-year survival analysis.
- Stang A et al. Research on diagnostic and prognostic significance of α-fetoprotein in hepatocellular carcinoma.
- Research on ALPPS (Associating Liver Partition and Portal vein Ligation for Staged hepatectomy) — Hamburg Barmbek Experience of 58 cases, 2017.
- 68+ peer-reviewed publications in total with 3,461+ citations.
Ongoing Research & Clinical Interests
- Selective Internal Radiation Therapy (SIRT) for liver malignancies
- Radiofrequency ablation outcomes in liver metastases
- Hepatocellular carcinoma diagnostic and prognostic biomarkers
- Contrast-enhanced abdominal ultrasound in oncology
- DKG-certified oncology center quality improvement
Estimated Treatment Costs
| Procedure / Consultation | Estimated Cost (INR) | Estimated Cost (USD) |
|---|---|---|
| Oncology Consultation (Germany) | ₹15,000 – ₹35,000 | $180 – $420 |
| Selective Internal Radiation Therapy (SIRT) | ₹20,00,000 – ₹40,00,000 | $24,000 – $48,000 |
| Radiofrequency Ablation (RFA) for Liver Tumor | ₹6,00,000 – ₹15,00,000 | $7,200 – $18,000 |
| Systemic Chemotherapy (per year) | ₹8,00,000 – ₹25,00,000 | $9,600 – $30,000 |
| Immunotherapy (Checkpoint Inhibitor, per year) | ₹20,00,000 – ₹50,00,000 | $24,000 – $60,000 |
| Palliative Care Program | ₹5,00,000 – ₹15,00,000 | $6,000 – $18,000 |
*Indicative estimates only. Actual costs subject to hospital pricing, case complexity, and insurance. Contact Cancer Rounds for a personalised quote.
Frequently Asked Questions
1. What advanced technologies does Dr. med. Axel Stang use in Medical Oncologist, Pediatric Hematologist treatment?
Prof. Dr. med. Axel Stang uses Selective Internal Radiation Therapy (SIRT), radiofrequency ablation for liver tumors, chemosaturation, modern immunotherapy and targeted therapy, contrast-enhanced abdominal ultrasound, and comprehensive DKG-certified oncology protocols — a full modern toolkit that establishes him as a leading medical oncologist specialist in Hamburg, Germany.
2. What conditions does Dr. med. Axel Stang specialize in treating?
Prof. Dr. med. Axel Stang specialises in acute and chronic leukemias, Hodgkin and non-Hodgkin lymphoma, multiple myeloma, myelodysplastic syndrome, solid tumors (lung, GI, breast, genitourinary), liver metastases, hepatocellular carcinoma, cholangiocarcinoma, inoperable liver malignancies, and advanced-stage cancer palliative care — comprehensive care for international patients seeking best cancer treatment in Germany.
3. How do I book an appointment with Dr. med. Axel Stang?
Appointments with Prof. Dr. med. Axel Stang can be booked directly through the Cancer Rounds website or by contacting their international patient department for priority scheduling.
4. Can international patients receive treatment from Dr. med. Axel Stang?
Yes. Cancer Rounds provides full assistance for international patients seeking treatment from Prof. Dr. med. Axel Stang, including medical visa invitation letters, airport transfers, and local accommodation coordination.
5. What support is available for international patients?
International patients benefit from a dedicated concierge service provided by Cancer Rounds, including language interpretation, financial counselling, and pre-travel virtual consultations to review medical records before arrival.
6. Does Dr. med. Axel Stang offer second opinions for Medical Oncologist, Pediatric Hematologist cases?
Yes. Second opinion consultations can be arranged via Cancer Rounds for patients who wish to review their diagnosis or treatment plan with an expert medical oncologist specialist in Hamburg, Germany, especially for complex hematologic malignancies, liver metastases, and inoperable liver tumors.
